
Opinion|Videos|December 8, 2025
Integrating Patient Reported Outcomes to Capture Meaningful Clinical Benefit
Author(s)Fiona C. Baker, PhD
Fiona C. Baker, PhD, emphasizes the importance of patient-reported outcomes in assessing elinzanetant’s overall benefit, including insights on symptom recurrence and quality-of-life improvements.
Advertisement
Episodes in this series

This discussion highlights the essential role of patient-reported outcomes in assessing treatment success, since women’s perceptions of reduced awakenings, improved sleep quality, and less severe hot flashes directly influence daytime functioning and help-seeking behavior. Objective polysomnography results in NIRVANA—showing reductions in wakefulness and improved sleep continuity—provide strong corroboration of these subjective gains. The dual confirmation strengthens confidence in the therapy’s impact on real-world quality of life.
Advertisement
Related to this article

Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.

Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.

The Preeclampsia Foundation released 2 videos on postpartum recovery and long-term health after HDP.

Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.

A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.

A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Maternal egg, peanut diet in pregnancy, and associated infant allergy
2
The annual well-woman visit needs an upgrade
3
Perimenopause and mental health: Beyond hormonal vs psychological
4
Wen Shen, MD, on screening red flags during perimenopause care
5

